CINC
Price:
$29.06
Market Cap:
$1.27B
CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of treatments for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial to treat chronic kidney diseases. CinCor Pharma, Inc. has a license agreement with F. Hoffman-La Roche Ltd. and Hoffmann-La Roche Inc. The company was incorporated in 2018 and is headquartered in Boston, Massachusetts.
Industry
Biotechnology
IPO Date
2022-01-07
Stock Exchange
NASDAQ
Ticker
CINC
According to CinCor Pharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.14B. This represents a change of 82.99% compared to the average of 620.36M of the last 4 quarters.
The mean historical Enterprise Value of CinCor Pharma, Inc. over the last ten years is 381.44M. The current 1.14B Enterprise Value has changed 29.66% with respect to the historical average. Over the past ten years (40 quarters), CINC's Enterprise Value was at its highest in in the September 2022 quarter at 1.05B. The Enterprise Value was at its lowest in in the March 2021 quarter at 0.
Average
381.44M
Median
364.41M
Minimum
349.82M
Maximum
430.10M
Discovering the peaks and valleys of CinCor Pharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 22.95%
Maximum Annual Enterprise Value = 430.10M
Minimum Annual Increase = -4.00%
Minimum Annual Enterprise Value = 349.82M
Year | Enterprise Value | Change |
---|---|---|
2021 | 430.10M | 22.95% |
2020 | 349.82M | -4.00% |
The current Enterprise Value of CinCor Pharma, Inc. (CINC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
381.44M
5-year avg
381.44M
10-year avg
381.44M
CinCor Pharma, Inc.’s Enterprise Value is
Company | Enterprise Value | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CinCor Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CinCor Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is CinCor Pharma, Inc.'s Enterprise Value?
What is the highest Enterprise Value for CinCor Pharma, Inc. (CINC)?
What is the 3-year average Enterprise Value for CinCor Pharma, Inc. (CINC)?
What is the 5-year average Enterprise Value for CinCor Pharma, Inc. (CINC)?
How does the current Enterprise Value for CinCor Pharma, Inc. (CINC) compare to its historical average?